These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12607495)

  • 1. [National guidelines for treatment of chronic myelogenous leukemia].
    Wisløff F; Brinch L; Hammerstrøm J
    Tidsskr Nor Laegeforen; 2003 Jan; 123(2):157-9. PubMed ID: 12607495
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronic myeloid leukemia--treatment].
    Stoetzer OJ; Hentrich M; Salat C
    Dtsch Med Wochenschr; 2002 Dec; 127(49):2621-4. PubMed ID: 12469275
    [No Abstract]   [Full Text] [Related]  

  • 3. [Interferon-alpha in the treatment of chronic myeloid leukemia].
    Guilhot F
    Rev Prat; 1999 Mar; 49(5):464-6. PubMed ID: 10358394
    [No Abstract]   [Full Text] [Related]  

  • 4. [EBM in the treatment of CML].
    Ohnishi K
    Rinsho Ketsueki; 2005 Jun; 46(6):410-7. PubMed ID: 16447722
    [No Abstract]   [Full Text] [Related]  

  • 5. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
    Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
    N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment strategies for chronic myeloid leukemia].
    Jinnai I
    Rinsho Ketsueki; 2005 Jan; 46(1):1-6. PubMed ID: 16708910
    [No Abstract]   [Full Text] [Related]  

  • 7. NCCN Practice Guidelines for Chronic Myelogenous Leukemia.
    Berman E; Clift RA; Copelan EA; Emanuel PD; Erba HP; Glenn MJ; Greenberg PL; Jones RJ; O'Brien S; Saba HI; Schilder R; Snyder DS; Soiffer RJ; Tallman MS; Wetzler M; Ravandi-Kashani F; Kantarjian H; Talpaz M;
    Oncology (Williston Park); 2000 Nov; 14(11A):229-40. PubMed ID: 11195415
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changing concept of conventional therapy in chronic myelogenous leukemia].
    Ueda R
    Rinsho Ketsueki; 2000 Apr; 41(4):268-71. PubMed ID: 10846452
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chronic myeloid leukemia: current pathogenetic aspects and new therapeutic approaches (a foreign literature review)].
    Petukhov VI; Strozha IL; Bondare DK
    Ter Arkh; 2001; 73(12):96-101. PubMed ID: 11858124
    [No Abstract]   [Full Text] [Related]  

  • 10. No known cause: leukemia research.
    Tecnologica; 2000; ():1, 3-6, 14. PubMed ID: 11010680
    [No Abstract]   [Full Text] [Related]  

  • 11. Tetrasomy of Philadelphia chromosome in myeloblastic crisis of chronic myelogenous leukemia.
    Oikawa H; Utsugisawa T; Murai K; Narigasawa Y; Miyairi Y; Shimosegawa K; Suzuki T; Kuriya S
    Int J Hematol; 1995 Jun; 61(4):229-30. PubMed ID: 8547613
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chronic myeloid leukemia: progress and prospects].
    Baccarani M; Russo D; Fanin R
    Haematologica; 1991 Jun; 76 Suppl 3():40-5. PubMed ID: 1752539
    [No Abstract]   [Full Text] [Related]  

  • 13. Current controversies on the role of interferon-alpha for therapy of chronic myeloid leukemia.
    Heimpel H; Allan NC; Baccarani M; Guilhot F; Hehlmann R; Horowitz M; Kluin-Nelemans J; Schaefer U; Storb R; Thaler J
    Bone Marrow Transplant; 1996 May; 17 Suppl 3():S39. PubMed ID: 8769699
    [No Abstract]   [Full Text] [Related]  

  • 14. Rendering the leukemia cell susceptible to attack.
    Sipkins DA
    N Engl J Med; 2009 Sep; 361(13):1307-9. PubMed ID: 19776414
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of accelerated and blastic phase of chronic myeloid leukemia with high-dose interferon alpha and hydroxyurea: a novel approach.
    Jehn U; Pötscher C; Heinemann V
    Leuk Lymphoma; 1995 Sep; 19(1-2):153-7. PubMed ID: 8574162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of chronic myelogenous leukemia].
    Shibata A
    Nihon Naika Gakkai Zasshi; 1993 Sep; 82(9):1318-30. PubMed ID: 8245626
    [No Abstract]   [Full Text] [Related]  

  • 17. Imatinib mesylate--the new gold standard for treatment of chronic myeloid leukemia.
    Peggs K; Mackinnon S
    N Engl J Med; 2003 Mar; 348(11):1048-50. PubMed ID: 12637616
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic myeloid leukemia with osteolytic bone involvement.
    Prabhash K; Loknath D; Babu KG; Hasib AG; Biswas S; Bapsy PP
    J Assoc Physicians India; 2003 Jul; 51():740-1. PubMed ID: 14621059
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chronic myeloid leukemia. New prospects for marrow autotransplantation].
    Carella AM; Carlier P; Nati S; Congiu A; Pierluigi D; Raffo MR
    Haematologica; 1991 Jun; 76 Suppl 3():337-51. PubMed ID: 1684348
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chronic myeloid leukemia].
    Hehlmann R
    Ther Umsch; 1996 Feb; 53(2):82-7. PubMed ID: 8629268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.